CGS Insider Trading

Insider Ownership Percentage: 43.12%
Insider Buying (Last 12 Months): A$20,640.00
Insider Selling (Last 12 Months): A$0.00

Cogstate Insider Trading History Chart

This chart shows the insider buying and selling history at Cogstate by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cogstate Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for CGS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Cogstate Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/16/2023Richard MohsInsiderBuy12,000A$1.72A$20,640.00
3/7/2023Bradley O'ConnorInsiderBuy32,500A$1.54A$50,180.00
12/3/2021Bradley O'ConnorInsiderIssued1,000,000A$2.33A$2,330,000.00
10/12/2021Richard van den BroekInsiderBuy100,000A$0.84A$84,000.00
9/14/2021Martyn MyerInsiderSell250,000A$1.77A$442,750.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Cogstate (ASX:CGS)

22.47% of Cogstate stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Cogstate logo
Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is also involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The company also provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2023, it had participated in approximately 1,800 academic research studies and 530 industry sponsored clinical trials. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Read More on Cogstate

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


2,002 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Cogstate?

Cogstate's top insider investors include:
  1. Bradley O'Connor (Insider)
  2. Richard Mohs (Insider)
Learn More about top insider investors at Cogstate.